Squamous cell carcinoma of the rectum is a rare rectal cancer that starts in the lining of the rectum. It often affects adults, and common symptoms can include rectal bleeding, pain, changes in bowel habits, or a feeling that the bowel does not fully empty. Early symptoms of squamous cell carcinoma of the rectum can look like more common rectal problems, so diagnosis may take time. Not everyone will have the same experience, but this cancer can be serious and may be life-threatening if it spreads or is found late. Treatment often involves radiation and chemotherapy, and some people also need surgery.
How many people live with Squamous cell carcinoma of the rectum?
Squamous cell carcinoma of the rectum is such a rare kind of rectal cancer that most cancer databases do not track it on its own, but about 2 million people worldwide were living with rectal cancer within 5 years of diagnosis (Global Cancer Observatory, 2022), and because this rare kind is often estimated to make up only about 0.1% to 0.3% of rectal cancers, that suggests roughly 2,000 to 6,000 people worldwide may be living with it; this is an estimate, not a direct count. In the United States, about 300,000 people were living with rectal cancer (SEER Program, 2021), which suggests roughly 300 to 900 people may be living with rectal squamous cell carcinoma, again as an estimate rather than a direct national count.
Overview
Squamous cell carcinoma of the rectumSymptoms
Squamous cell carcinoma of the rectum can cause rectal bleeding, pain, pressure, or a feeling that you still need to pass stool after going. Early symptoms of squamous cell carcinoma of the rectum may also include changes in bowel habits, mucus, or unexplained weight loss.
Outlook and prognosis
Squamous cell carcinoma of the rectum can often be treated successfully, especially when found early. Outlook depends mainly on stage, whether it has spread, and how well it responds to chemoradiation, with close follow-up needed because recurrence can happen.
Causes and risk factors
Squamous cell carcinoma of the rectum is linked to human papillomavirus, long-term inflammation, smoking, and a weakened immune system. Risk may also rise with HIV, prior pelvic radiation, and a history of anal or genital precancers.
Genetic influences
Genetics are not thought to be a major driver of squamous cell carcinoma of the rectum in most people. Unlike some cancers, inherited gene changes have not been clearly linked, and risk more often relates to non-genetic factors.
Diagnosis
Squamous cell carcinoma of the rectum is diagnosed with a rectal exam, endoscopy, and a biopsy to confirm cancer cells. Imaging scans help show the tumor size, exact location, and whether it has spread.
Treatment and drugs
Treatment for squamous cell carcinoma of the rectum often combines radiation and chemotherapy, and some people also need surgery. Care is tailored to the tumor stage, symptoms, and overall health, with close follow-up after treatment.
Symptoms
Squamous cell carcinoma of the rectum often shows up through bowel changes that start to interfere with daily life, such as bleeding, pain, or a new sense of urgency. You might notice small changes at first, and the early symptoms of squamous cell carcinoma of the rectum can look a lot like hemorrhoids, irritation, or other more common bowel problems. Some people have only mild symptoms at first, while others notice several changes at once.
Blood in or on the stool is one of the more common warning signs. It may look bright red on toilet paper or in the bowl, and even small but repeated bleeding should be checked.
Many people with squamous cell carcinoma of the rectum notice a lasting change in bowel habits, such as more constipation, more diarrhea, or stools that seem narrower than usual. What once felt effortless can start to require more energy or focus, especially if bowel movements become unpredictable.
Some may feel a strong need to have a bowel movement right away, even when little comes out. This can leave you going to the bathroom often and still feeling like the rectum is not fully empty.
Pain, pressure, or soreness in the rectum or lower pelvis can develop as the tumor irritates nearby tissue. For many, this can mean discomfort when sitting, passing stool, or even during routine movement.
How people usually first notice Squamous cell carcinoma of the rectum?
Many people first notice squamous cell carcinoma of the rectum because something changes with bowel movements that does not go away, such as rectal bleeding, pain, a feeling of pressure, or the sense that you still need to pass stool after you have already gone. Some also develop constipation, narrower stools, mucus, or a new lump or discomfort around the rectal area, and for many these first signs of squamous cell carcinoma of the rectum can be easy to mistake for hemorrhoids or other more common problems at first. If bleeding, pain, or a lasting change in bowel habits continues for more than a few weeks, that is usually the point when doctors recommend getting it checked.
Types of Squamous cell carcinoma of the rectum
Squamous cell carcinoma of the rectum can affect daily life in a few different ways, depending on where the tumor is, how large it is, and whether it has spread. Symptoms don’t always look the same for everyone. For many, the earliest changes involve bowel habits or rectal bleeding, while later changes may bring pain, weight loss, or more general signs of illness. When people ask about the types of squamous cell carcinoma of the rectum, doctors usually mean these common symptom patterns rather than separate disease subtypes.
Bowel changes
Many people with squamous cell carcinoma of the rectum notice changes in how they pass stool, such as constipation, diarrhea, narrower stools, or a feeling that the bowel does not empty fully. In everyday life, this may feel like needing to go again right after a bowel movement or spending more time in the bathroom without relief.
Bleeding signs
Rectal bleeding is a common symptom, and some may see bright red blood on toilet paper, in the toilet, or mixed with stool. Ongoing bleeding can also lead to anemia, which may cause tiredness, weakness, or shortness of breath even with light activity.
Pain and pressure
Some people with squamous cell carcinoma of the rectum develop rectal pain, pressure, or a constant urge to have a bowel movement even when little comes out. One person might mainly notice discomfort when sitting, while another feels cramping or pain during bowel movements.
Advanced symptoms
If the cancer grows further or spreads, symptoms can become more general and may include unexplained weight loss, loss of appetite, or ongoing fatigue. Early symptoms of squamous cell carcinoma of the rectum can be subtle, but more advanced disease may also cause pelvic pain or symptoms linked to spread in other parts of the body.
Can I slow down the onset of symptoms?
Probably not in any proven way: because squamous cell carcinoma of the rectum is very rare, there is no strong evidence that lifestyle changes or medicines can meaningfully delay when symptoms begin. Research suggests that not smoking, getting the HPV vaccine, which protects against a common virus linked to some squamous cancers, and treating long-term irritation or inflammation in the area may help lower risk for some people, but that is not the same as preventing this cancer, and the evidence for this specific cancer is limited. There is no standard screening or preventive medicine for people without symptoms, but getting rectal bleeding, pain, or lasting changes in bowel habits checked early can help find problems sooner, and caring for your overall health is still worthwhile even though it cannot promise a delay.
What genetics can tell you about symptoms
For squamous cell carcinoma of the rectum, genetics usually cannot predict exactly which symptoms someone will have, because symptoms are driven more by where the tumor is, how large it is, and whether it has spread. This means many living with this cancer may notice bleeding, pain, changes in bowel habits, or a feeling of pressure regardless of the tumor’s specific genetic changes. Researchers are studying whether certain tumor gene changes affect how aggressive the cancer is or when it starts, but for now genetics is much more useful for understanding the cancer’s biology and treatment options than for forecasting day-to-day symptoms.
Causes and risk factors
The exact cause of squamous cell carcinoma of the rectum is often unclear. Risk factors for squamous cell carcinoma of the rectum include long-term irritation or inflammation in the rectum and past radiation to the pelvis. Human papillomavirus infection and a weakened immune system can also raise risk. Smoking is another possible risk factor, while inherited gene changes are not a well-established main cause. It is rarely just one factor, and the mix often matters.
What are the most common causes or risk factors?
Squamous cell carcinoma of the rectum is very rare, and in many people the exact cause is not clear. The strongest known risk factors are long-term irritation or inflammation in the rectum, previous radiation treatment to the pelvis, infection with HPV, a common virus, smoking, and a weakened immune system, such as in people living with HIV or after an organ transplant. Unlike some other colorectal cancers, there is no single well-known inherited gene change that strongly explains most cases of this type.
Environmental and biological risk factors
Squamous cell carcinoma of the rectum is a very rare cancer, so its biological and environmental risk factors are less clearly mapped out than they are for more common rectal cancers. That said, biology and environment work hand in hand. In general, doctors look at factors that may keep the rectal lining inflamed, injured, infected, or less able to repair itself over time.
Persistent infection with high-risk human papillomavirus, especially HPV-16, may raise the chance of squamous cell carcinoma of the rectum. The link is not as firmly established as it is for anal cancer, but it is considered an important possible biological risk.
Long-term inflammation in the rectum can keep tissue irritated and may make abnormal cell changes more likely. This can happen with conditions such as ulcerative colitis, Crohn disease, or other ongoing inflammatory injury.
A weakened immune system can make it harder for the body to clear infections and repair damaged cells. This may increase the risk of squamous cell carcinoma of the rectum in people living with HIV or in those taking strong immune-suppressing medicines.
Previous radiation treatment to the pelvis can damage healthy tissue as well as cancer cells. Years later, that tissue injury may increase the risk of rare cancers, including squamous cell carcinoma of the rectum.
Genetic risk factors
Because the disease is so uncommon, the genetic risk factors for squamous cell carcinoma of the rectum are still not well mapped. For most people, there is no known inherited mutation that clearly explains why squamous cell carcinoma of the rectum develops, and most cases appear to be sporadic rather than strongly familial. In some cases, genetic testing can give a clearer picture of your personal risk, especially when there is a strong family history of colorectal or related cancers.
No proven mutation: At this time, no inherited gene change has been consistently linked to squamous cell carcinoma of the rectum. There is no standard genetic marker doctors use to predict this rare cancer in families.
Sporadic changes: Most reported cases seem to come from DNA changes that develop only in the rectal tumor over time. These are acquired changes, so they are usually not passed from a parent to a child.
Family history: A strong family history of colorectal, uterine, or several related cancers may prompt a closer genetic review. Even so, family history has not been proven to be a direct, specific risk factor for squamous cell carcinoma of the rectum.
Inherited syndromes: Inherited cancer syndromes such as Lynch syndrome or familial adenomatous polyposis raise the risk of colorectal cancer overall. However, they have not been clearly shown to be common genetic causes of squamous cell carcinoma of the rectum.
Lifestyle risk factors
Because rectal squamous cell carcinoma is rare, lifestyle data are less specific than they are for more common colorectal cancers. Still, the main lifestyle risk factors for squamous cell carcinoma of the rectum are thought to overlap with those linked to rectal and colorectal cancer overall. Habits that promote chronic inflammation, excess body weight, and poorer metabolic health may raise risk and can also affect recovery and long-term outcomes.
Tobacco use is one of the strongest lifestyle factors linked to many squamous cancers and may also increase the risk of squamous cell carcinoma of the rectum. Smoking can promote DNA damage, chronic inflammation, and poorer healing during cancer treatment.
Heavy alcohol intake is associated with higher risk for several gastrointestinal cancers and may contribute to rectal cancer risk as well. It can worsen nutritional status, irritate tissues, and make it harder for the body to recover during treatment.
Overweight and obesity are linked with higher colorectal cancer risk and may also matter for this rare rectal cancer subtype. Excess body fat can increase inflammation, insulin resistance, and hormone-related signals that support tumor growth.
A sedentary lifestyle is associated with higher colorectal cancer risk and poorer overall metabolic health. Regular physical activity may help lower cancer risk indirectly by improving weight control, insulin sensitivity, and inflammation levels.
Risk prevention
Because squamous cell carcinoma of the rectum is rare, there is no guaranteed way to prevent it, but some steps may lower risk and help find changes sooner. Prevention is about lowering risk, not eliminating it completely. Many of the same risk factors linked to nearby squamous cancers, especially human papillomavirus, smoking, and a weakened immune system, may matter here too. Paying attention to new rectal symptoms and staying up to date with care can make a real difference.
Getting the HPV vaccine can lower the chance of infection with high-risk HPV types that are linked to squamous cancers. It works best before exposure, but some adults may still benefit based on age and risk.
Using condoms or other barriers during anal sex may reduce HPV spread, though it does not remove the risk بالكامل. Limiting exposure to sexually transmitted infections and seeking care for new symptoms can also help.
Smoking can damage tissues and weaken the body's ability to control abnormal cell growth. Quitting smoking may lower cancer risk over time and supports overall healing and immune health.
People living with HIV or other causes of lowered immunity may have a higher risk of HPV-related cancers. Staying on prescribed treatment and keeping regular follow-up visits can help the immune system work better.
Can you prevent Squamous cell carcinoma of the rectum?
There is no sure way to prevent squamous cell carcinoma of the rectum, and because this cancer is very rare, doctors still do not fully understand why some people get it. Risk may be lower for people who do not smoke, who reduce their chance of getting HPV, a common virus linked to some cancers, through vaccination and safer sex, and who get treatment for long-lasting irritation or inflammation in the rectal area. These steps cannot guarantee prevention, but they may help lower risk.
Transmission
Squamous cell carcinoma of the rectum is not an infectious disease, so it cannot be passed from one person to another through touch, sex, shared toilets, blood, or the air. If you are living with squamous cell carcinoma of the rectum, you cannot give it to a partner, family member, or caregiver.
This cancer is also not usually something that is directly inherited from a parent. When people ask how infectious squamous cell carcinoma of the rectum is, the answer is that it is not infectious at all, and it usually develops from changes that build up in rectal cells over time rather than from any kind of person-to-person spread.
When to test your genes
For squamous cell carcinoma of the rectum, genetic testing is not usually used for early detection. It may be considered after diagnosis, especially if the cancer is advanced, recurrent, or not responding as expected, because tumor testing can sometimes help guide treatment. Inherited gene testing is usually reserved for people with a strong family history of colorectal or related cancers.
Diagnosis
Squamous cell carcinoma of the rectum is usually investigated after symptoms such as rectal bleeding, pain, a change in bowel habits, or a feeling that the bowel is not fully empty lead to a medical visit. Because these problems can overlap with hemorrhoids, infections, or more common rectal cancers, the diagnosis often takes a few steps to confirm. It’s natural to worry when symptoms don’t have a clear explanation. In practice, the diagnosis of squamous cell carcinoma of the rectum relies on finding the tumor, taking a tissue sample, and checking whether it has spread.
Doctors ask about bleeding, pain, bowel changes, weight loss, and how long symptoms have been going on. They also review past radiation treatment, infections, immune system problems, smoking, and other risk factors that may help explain the findings.
A physical exam often includes a digital rectal exam, where a doctor gently feels for a mass or tender area inside the rectum. This can give an early clue about the tumor’s size and location, although it cannot confirm the exact cancer type.
Flexible sigmoidoscopy or colonoscopy lets doctors look directly at the rectum and lower bowel with a thin camera. This helps them see the abnormal area, check for other possible causes of symptoms, and choose the best place for biopsy.
A biopsy is the key test because only a tissue sample can confirm squamous cell carcinoma of the rectum. A pathologist examines the cells under a microscope to tell this cancer apart from other rectal tumors and to make sure it did not start somewhere else and spread to the rectum.
How is Squamous cell carcinoma of the rectum diagnosed?
Doctors usually diagnose squamous cell carcinoma of the rectum by examining the rectum with a thin camera tube and taking a small tissue sample, called a biopsy, because the lab test on that sample is what confirms the cancer. They also do a physical exam and usually order scans, such as MRI, CT, or sometimes PET, to see how far the cancer has grown and to help make sure it started in the rectum rather than somewhere else. Blood tests can help check overall health, but they cannot confirm this cancer on their own.
Stages of Squamous cell carcinoma of the rectum
Squamous cell carcinoma of the rectum is usually described by cancer stage, which tells you how far it has grown into the rectum or spread beyond it. In daily life, this can help explain why some people have only mild bowel changes at first, while others are dealing with pain, bleeding, or symptoms from spread elsewhere. Step by step, they look for the most likely explanations using scans, an exam, and a biopsy, because the early symptoms of squamous cell carcinoma of the rectum can overlap with other rectal problems.
Stage 0
Abnormal cells are limited to the inner lining of the rectum. They have not grown deeper into the wall or spread to lymph nodes or other organs.
Stage 1
The cancer has grown into the wall of the rectum but remains localized. It has not spread to nearby lymph nodes or distant parts of the body.
Stage 2
The tumor has grown more deeply through the rectal wall or into nearby tissues. There is still no sign of spread to nearby lymph nodes or distant organs.
Stage 3
The cancer may be any size in or around the rectum, but it has spread to nearby lymph nodes. It has not spread to distant organs such as the liver or lungs.
Stage 4
The cancer has spread to distant parts of the body. Common sites can include the liver, lungs, or the lining of the abdomen.
Outlook and prognosis
Outlook for squamous cell carcinoma of the rectum depends mainly on how far the cancer has spread, whether lymph nodes are involved, and how well it responds to treatment. Because this is a rare tumor, prognosis estimates are less precise than for the more common rectal adenocarcinoma, but patients with localized disease can do well, especially when treated with chemoradiation, which is often used as first-line therapy. Survival is generally better for early-stage cancers and worse for tumors that are bulky, recurrent, or metastatic at diagnosis. Reported outcomes suggest many patients with nonmetastatic disease achieve durable remission, while metastatic disease is associated with a substantially lower chance of long-term survival. Mortality is therefore closely tied to stage: deaths are uncommon in successfully treated localized cases but rise significantly once the cancer has spread or cannot be controlled with therapy. Ongoing follow-up is important because recurrence can occur, particularly in the first few years after treatment.
Long-term effects
For many people, the biggest long-term questions are whether the cancer comes back, how treatment affects bowel function, and how daily life feels months to years later. The long-term picture is often shaped by the stage at diagnosis, whether treatment worked fully, and overall health. Some people remain cancer-free after treatment, while others need ongoing monitoring for recurrence or treatment-related problems. Because squamous cell carcinoma of the rectum is rare, follow-up plans are often tailored to the individual rather than based on one fixed pathway.
One of the main long-term concerns is that squamous cell carcinoma of the rectum can return in the rectum, nearby tissues, or elsewhere in the body. The risk is usually higher in the first few years after treatment, which is why scans, exams, and endoscopy may continue over time.
Long-term bowel effects can include urgency, frequent stools, diarrhea, constipation, or feeling that the bowel does not empty fully. For many, this can mean planning trips around bathroom access or avoiding certain foods that seem to trigger symptoms.
Some people have ongoing discomfort, pressure, or pain in the rectum or pelvis after treatment. This may come from scarring, nerve irritation, or lasting inflammation, and it can affect sitting, exercise, and sexual activity.
Rectal bleeding or mucus may continue for some people, especially after radiation or if the lining of the rectum stays fragile. New or worsening bleeding should be checked promptly because it can overlap with early symptoms of rectal cancer recurrence.
How is it to live with Squamous cell carcinoma of the rectum?
Living with squamous cell carcinoma of the rectum can make daily life feel smaller and less predictable, because pain, bleeding, bowel urgency, fatigue, and the demands of treatment may affect work, sleep, meals, travel, and confidence about being away from a bathroom. Many people also carry an emotional load, with understandable worry about the cancer itself, body image, intimacy, and what lies ahead, especially during radiation, chemotherapy, or surgery. The effects often reach the people around you as well, since family and friends may take on caregiving, transportation, household tasks, and emotional support, which can be tiring for them too, even as close communication and practical help often make day-to-day life more manageable.
Treatment and drugs
Treatment for squamous cell carcinoma of the rectum often aims to control the cancer, ease symptoms, and protect bowel function as much as possible. Many people with squamous cell carcinoma of the rectum are treated with a combination of radiation therapy and chemotherapy, because these treatments can work together to shrink or destroy the cancer and may help some avoid major surgery. If the cancer does not respond fully, comes back, or has spread, surgery may still be needed, and some living with squamous cell carcinoma of the rectum may also need drug treatment to help with pain, nausea, or bowel problems during care. Not every treatment works the same way for every person, so your cancer team will tailor the plan to the stage of the cancer, your overall health, and whether you are dealing with early symptoms of squamous cell carcinoma of the rectum or more advanced disease.
Can you cure Squamous cell carcinoma of the rectum?
Sometimes, yes. If squamous cell carcinoma of the rectum is found early and responds well to treatment, some people can be cured, often with a mix of radiation and anti-cancer medicine, and sometimes surgery. If it has spread or comes back, treatment may still shrink the cancer, ease symptoms, and help people live longer, but a cure is less likely.
Non-drug treatment
Day-to-day, treatment for squamous cell carcinoma of the rectum often centers on getting rid of the tumor while protecting bowel function, comfort, and quality of life. Alongside medicines, non-drug therapies often include radiation, procedures or surgery in selected cases, and supportive care to help with eating, strength, and bowel changes. The best plan depends on the tumor size and location, whether nearby tissues are involved, and how your body is coping with symptoms such as pain, bleeding, or trouble passing stool.
Radiation uses focused high-energy beams to damage cancer cells in the rectum. It is often a main part of treatment for squamous cell carcinoma of the rectum, especially when doctors are trying to avoid major surgery.
Surgery may be used if the cancer does not fully respond to initial treatment, comes back, or is causing a blockage, heavy bleeding, or severe pain. The type of operation depends on how much of the rectum and nearby tissue are involved.
Some people need procedures to relieve symptoms quickly, such as opening a blockage or controlling bleeding. For many, treatment begins not at the pharmacy, but with practical steps that make it easier to pass stool, eat, and recover.
Eating can become harder during treatment because of pain, diarrhea, fatigue, or low appetite. A dietitian can help you maintain weight, fluids, and protein, which may support healing and energy.
Your genes may have an impact on how drugs work for you
For people living with squamous cell carcinoma of the rectum, treatment often includes radiation plus chemotherapy, and inherited differences in your genes can sometimes affect how your body handles these medicines. Some people break down certain chemotherapy drugs more slowly, which can make side effects like severe diarrhea, mouth sores, low blood counts, or extreme tiredness more likely, while others may not get the same benefit from treatment. This kind of gene-based medicine, called pharmacogenomics, is not used for every person with this cancer, but in some cases it can help doctors choose safer doses or avoid a drug that may cause more harm than help.
Pharmacological treatments
Drug treatment for squamous cell carcinoma of the rectum often centers on chemotherapy, usually given with radiation rather than as medicine alone. Because this cancer is rare, doctors often use drug plans similar to those used for squamous cancers of the anal area, tailored to the stage and your overall health. Not everyone responds to the same medication in the same way. For many people, the main goal is to shrink the cancer, improve the chance of local control, and treat any spread if it has moved beyond the rectum.
Fluorouracil, often called 5-FU, is one of the main drugs used in treatment for squamous cell carcinoma of the rectum. It is commonly given together with radiation and mitomycin C to make cancer cells more sensitive to treatment. In some cases, it is delivered by continuous infusion over several days.
Capecitabine is a tablet form of chemotherapy that can sometimes be used instead of 5-FU during chemoradiation. It works in a similar way but is taken by mouth, which some people find more convenient. Doctors still monitor blood counts, diarrhea, hand-foot soreness, and other side effects closely.
Mitomycin C is often paired with 5-FU or capecitabine during radiation treatment. Its role is to boost the effect of chemoradiation, especially for cancer that is still mainly in the pelvis. Because it can lower blood counts, careful lab monitoring is important during treatment.
Cisplatin is another chemotherapy drug that may be used in some treatment plans, especially when mitomycin C is not the best fit or when disease has come back. Some medicines work quickly, while others are chosen because they fit better with a person’s other health needs and prior treatments. Kidney function, hearing, and nerve symptoms may need close follow-up with cisplatin.
Genetic influences
For most people with squamous cell carcinoma of the rectum, inherited genes do not seem to be the main reason it develops. It’s natural to ask whether family history plays a role, but this rare cancer is more often linked to DNA changes that build up in rectal cells over time rather than a gene change passed down from a parent. Because squamous cell carcinoma of the rectum is uncommon, research on inherited risk is limited, and no single gene has been shown to explain most cases. Some inherited cancer syndromes can raise the risk of cancers in the lower digestive tract more broadly, but a direct, well-established link to rectal squamous cell carcinoma is not clear. If you are wondering whether squamous cell carcinoma of the rectum is hereditary, your doctor may review your personal and family cancer history and sometimes suggest genetic counseling if that history points to a wider inherited cancer pattern.
Is Squamous cell carcinoma of the rectum genetic?
Genetics are not thought to be a major driver of squamous cell carcinoma of the rectum in most people. Unlike some cancers, inherited gene changes have not been clearly linked, and risk more often relates to non-genetic factors.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant linked to a condition points to a possible association rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many people with squamous cell carcinoma of the rectum, treatment often involves radiation and chemotherapy, but genes can still shape which drugs are safest and most useful. Not every difference in response is genetic, but doctors may sometimes look at both your inherited genes and gene changes inside the cancer before finalizing a plan. With chemotherapy drugs such as 5-FU or capecitabine, an inherited change in a gene called DPYD can make it harder for the body to clear the medicine, which can raise the risk of severe side effects, so a lower dose or a different drug may be needed. If irinotecan is being considered later, changes in another gene, UGT1A1, can also affect how safely that drug is handled. If squamous cell carcinoma of the rectum comes back or has spread, testing the tumor for certain markers, such as problems with DNA repair, may sometimes help show whether immunotherapy could be an option. Because this cancer is rare, genetic testing for squamous cell carcinoma of the rectum is usually just one part of treatment planning, along with the stage of the cancer, your overall health, and how the tumor responds to earlier treatment.
Interactions with other conditions
For many living with squamous cell carcinoma of the rectum, other health conditions can affect how symptoms show up and how treatment is planned. Problems such as HIV infection, a weakened immune system after an organ transplant, or long-term inflammatory bowel disease can make this cancer more likely to develop and may also make care more complex. Doctors call it a comorbidity when two conditions occur together. In real life, that can mean rectal bleeding, pain, or changes in bowel habits are first mistaken for a flare of another bowel condition, which can delay attention to the early symptoms of squamous cell carcinoma of the rectum. This cancer can also overlap with other HPV-related diseases, including cancers of the anus, cervix, vulva, vagina, or penis, so your care team may look for related problems if the history suggests it. If squamous cell carcinoma of the rectum is present alongside chronic infection, immune suppression, or another pelvic cancer, treatment often needs closer coordination between cancer, bowel, and infectious disease specialists.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Squamous cell carcinoma of the rectum?
Other problems can look similar, especially hemorrhoids, anal fissures, which are small tears near the anus, inflammatory bowel disease, and the more common type of rectal cancer. Anal cancer can also cause similar bleeding, pain, or changes in bowel habits because it affects a nearby area. Since these symptoms overlap so much, doctors usually need an exam and tests to tell the difference.
History
People living with rectal cancer symptoms often describe a long stretch of uncertainty before a clear answer is found. That has been especially true for squamous cell carcinoma of the rectum, an uncommon form of rectal cancer that was not well understood in earlier decades because it can look a lot like other tumors in the same area.
Early medical reports mainly focused on what doctors could see under the microscope and on how the tumor behaved over time. Because this cancer is rare, many of the first descriptions came from individual case reports rather than large studies, so ideas about where it started and how best to treat it changed gradually. In recent decades, awareness has grown, and squamous cell carcinoma of the rectum has been recognized more clearly as a distinct diagnosis rather than being grouped loosely with other cancers of the rectum or nearby anal canal.
As imaging, pathology, and cancer staging improved, doctors became better at telling these tumors apart. That mattered in real life: treatment decisions could affect bowel function, pain control, and whether someone might need major surgery, radiation, chemotherapy, or a combination of these. Over time, care shifted from relying mostly on surgery toward more tailored treatment plans based on the exact tumor type, its location, and how far it had spread.
The history of squamous cell carcinoma of the rectum is also a good example of how rare diseases become better understood step by step. Early descriptions were limited, but they helped later researchers compare cases, refine diagnostic rules, and study outcomes more carefully. Knowing this history helps explain why older information about this cancer may sound inconsistent, and why people diagnosed today usually benefit from more accurate testing and a more individualized treatment approach than was possible in the past.